Literature DB >> 31858331

Improving motor performance in Parkinson's disease: a preliminary study on the promising use of the computer assisted virtual reality environment (CAREN).

Rocco Salvatore Calabrò1, Antonino Naro2, Vincenzo Cimino2, Antonio Buda2, Giuseppe Paladina2, Giuseppe Di Lorenzo2, Alfredo Manuli2, Demetrio Milardi2, Placido Bramanti2, Alessia Bramanti2.   

Abstract

BACKGROUND: Parkinson's disease (PD) is a neurodegenerative disorder characterized by various motor symptoms including balance and gait impairment. Several studies have shown that physiotherapy, cueing techniques, treadmill training, and cognitive movement strategies are useful in improving balance and gait in patients with PD. Devices employing virtual reality (VR) have been shown to be promising in neurorehabilitation as they can provide the patients with multisensory stimulation creating a realistic environment and improve the motivation and the adhesion of patients to the rehabilitation program. This preliminary study is aimed at testing the efficacy and feasibility of gait training based on the computer-assisted virtual reality environment (CAREN) in a sample of PD.
METHODS: In this preliminary study, 22 outpatients affected by PD who attended the Behavioral and Robotic Neurorehab Laboratory of the IRCCS Neurolesi between August 2017 and October 2018 were enrolled. All PD patients underwent 20 conventional physiotherapy sessions followed by 3-month of rest. Then, the patients were provided with 20 sessions of CAREN training. Gait and balance performances were rated before, after each training protocol, and 3 months later. Gait analysis was also performed before and after CAREN training.
RESULTS: All patients completed both of the rehabilitation trainings without any adverse event. All considered scales improved significantly at the end of both rehabilitation treatments. However, patients presented with a greater clinical improvement after the CAREN training, compared with conventional physiotherapy. In particular, patients walked faster and with more stability, with wider, longer steps.
CONCLUSIONS: Even though further neurophysiological details are required to identify the patients who may benefit from CAREN training, our findings suggest that this innovative device is an effective and feasible tool to train balance and gait in patients with PD.

Entities:  

Keywords:  CAREN; Gait rehabilitation; Parkinson's Disease; Risk of falls; Virtual reality

Year:  2019        PMID: 31858331     DOI: 10.1007/s10072-019-04194-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  36 in total

1.  Rehabilitation treatment of gait in patients with Parkinson's disease with freezing: a comparison between two physical therapy protocols using visual and auditory cues with or without treadmill training.

Authors:  Giuseppe Frazzitta; Roberto Maestri; Davide Uccellini; Gabriella Bertotti; Paola Abelli
Journal:  Mov Disord       Date:  2009-06-15       Impact factor: 10.338

Review 2.  Understanding disability in Parkinson's disease.

Authors:  Lisa M Shulman
Journal:  Mov Disord       Date:  2010       Impact factor: 10.338

3.  Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions?

Authors:  A M Bonnet; Y Loria; M H Saint-Hilaire; F Lhermitte; Y Agid
Journal:  Neurology       Date:  1987-09       Impact factor: 9.910

4.  Improvements in gait speed and weight shift of persons with traumatic brain injury and vestibular dysfunction using a virtual reality computer-assisted rehabilitation environment.

Authors:  Pinata H Sessoms; Kim R Gottshall; John-David Collins; Amanda E Markham; Kathrine A Service; Seth A Reini
Journal:  Mil Med       Date:  2015-03       Impact factor: 1.437

5.  Cognitive rehabilitation using immersive virtual reality at young age: A case report on traumatic brain injury.

Authors:  Rosaria De Luca; Simona Portaro; Maria Le Cause; Carmen De Domenico; Maria Grazia Maggio; Maria Cristina Ferrera; Grazia Giuffrè; Alessia Bramanti; Rocco Salvatore Calabrò
Journal:  Appl Neuropsychol Child       Date:  2019-03-06       Impact factor: 1.493

6.  Mortality and Revision Surgery Are Increased in Patients With Parkinson's Disease and Fractures of the Femoral Neck.

Authors:  Mark S Karadsheh; Edward K Rodriguez; Mitchel B Harris; Mitchel Harris; David Zurakowski; Robert Lucas; Michael J Weaver; Michael Weaver
Journal:  Clin Orthop Relat Res       Date:  2015-03-24       Impact factor: 4.176

7.  Falls in frequent neurological diseases--prevalence, risk factors and aetiology.

Authors:  Henning Stolze; Stephan Klebe; Christiane Zechlin; Christoph Baecker; Lars Friege; Günther Deuschl
Journal:  J Neurol       Date:  2004-01       Impact factor: 4.849

Review 8.  Falls and freezing of gait in Parkinson's disease: a review of two interconnected, episodic phenomena.

Authors:  Bastiaan R Bloem; Jeffrey M Hausdorff; Jasper E Visser; Nir Giladi
Journal:  Mov Disord       Date:  2004-08       Impact factor: 10.338

Review 9.  Virtual reality for stroke rehabilitation.

Authors:  Kate E Laver; Stacey George; Susie Thomas; Judith E Deutsch; Maria Crotty
Journal:  Cochrane Database Syst Rev       Date:  2015-02-12

10.  Virtual reality-based cognitive-motor training for middle-aged adults at high Alzheimer's disease risk: A randomized controlled trial.

Authors:  Glen M Doniger; Michal Schnaider Beeri; Alex Bahar-Fuchs; Amihai Gottlieb; Anastasia Tkachov; Hagar Kenan; Abigail Livny; Yotam Bahat; Hadar Sharon; Oran Ben-Gal; Maya Cohen; Gabi Zeilig; Meir Plotnik
Journal:  Alzheimers Dement (N Y)       Date:  2018-03-27
View more
  1 in total

1.  Effect of Immersive Virtual Reality by a Computer Assisted Rehabilitation Environment (CAREN) in Juvenile Huntington's Disease: A Case Report.

Authors:  Roberta Cellini; Giuseppe Paladina; Giacomo Mascaro; Maria Antonietta Lembo; Antonino Lombardo Facciale; Maria Cristina Ferrera; Bartolo Fonti; Luca Pergolizzi; Piero Buonasera; Placido Bramanti; Emanuela Mazzon
Journal:  Medicina (Kaunas)       Date:  2022-07-11       Impact factor: 2.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.